Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Do cytogenetic abnormalities precede morphologic abnormalities in a developing malignant condition?

Jill K Northup1, Swarupa A Gadre, Yimin Ge

  • 1Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.

European Journal of Haematology
|February 23, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A cross-national comparison of nonmedical and medical use of psychedelic drugs in the international cannabis policy study.

The International journal on drug policy·2026
Same author

Mental Health Care Utilization Following Eviction Moratorium Expirations.

JAMA health forum·2026
Same author

A rare case of multifocal vulvar carcinoma of mammary gland type (AMGT) with mucinous features: Differential diagnosis and literature review.

Gynecologic oncology reports·2026
Same author

Impact of State Telemedicine Policies on Substance Use Disorder Treatment During the COVID-19 Pandemic.

Journal of general internal medicine·2026
Same author

Lifting eviction moratoria shifted treatment for substance use disorders.

Health affairs scholar·2026
Same author

Stage- and smoking-associated microRNA expression in lung adenocarcinoma.

Translational lung cancer research·2025
Same journal

Outsmarting Antigen Escape: Next-Generation CAR T Cell Engineering Strategies for Durable Remissions in Hematologic Malignancies.

European journal of haematology·2026
Same journal

Haploidentical Sibling Donors for Pediatric Patients: The Perfect Mismatch?

European journal of haematology·2026
Same journal

Analysis of CD8 Cytotoxic T-Cells in Patients With Myelodysplastic Neoplasms and T-Cell Large Granulocyte Lymphocytic Leukemia.

European journal of haematology·2026
Same journal

Platelet Counts During Pregnancy as Predictor of Subsequent Myeloproliferative Neoplasm.

European journal of haematology·2026
Same journal

Renal Dysfunction Complicating the Management of Hematologic Diseases.

European journal of haematology·2026
Same journal

Epstein-Barr Virus MicroRNAs as Key Regulators of Lymphoma Pathogenesis: Immune Evasion Mechanisms and Therapeutic Opportunities.

European journal of haematology·2026
See all related articles

Cytogenetic evaluation is crucial for cancer management, as genetic changes can precede visible signs. Overlooking these genetic markers may lead to incomplete patient care for malignant disorders.

Area of Science:

  • Oncology
  • Cytogenetics
  • Hematology

Background:

  • Cytogenetic evaluation of bone marrow and neoplastic tissues is vital for patient management and prognosis in malignant diseases.
  • Current practices often prioritize hematologic and morphologic changes, potentially overlooking critical genetic information.

Observation:

  • Two cases illustrate discrepancies between morphologic and cytogenetic findings in lymphoma patients.
  • Case 1: A non-Hodgkin's lymphoma patient with no morphologic signs of progression showed high-grade lymphoma-associated cytogenetic abnormalities.
  • Case 2: A patient with blastic natural killer leukemia/lymphoma had a morphologically normal bone marrow with cytogenetic evidence of Burkitt's lymphoma.

Findings:

  • Cytogenetic studies revealed significant clonal abnormalities in both cases, indicating malignancy despite differing morphologic presentations.

Related Experiment Videos

  • The findings challenge the sole reliance on hematologic and morphologic assessments for diagnosing and managing lymphoma.
  • Genetic alterations were observed to precede observable morphologic changes in these malignant conditions.

    • Implications:

    • Cytogenetic evaluation is essential for accurate diagnosis, prognosis, and treatment planning in hematologic malignancies.
    • Integrating cytogenetic data can prevent incomplete or inaccurate patient care by identifying underlying genetic drivers of disease.
    • These cases underscore the need to consider cytogenetic analysis as a primary diagnostic tool in complex hematologic disorders.